These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1499660)

  • 1. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y; Katz JL; Suzuki T
    Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for the implication of a kappa-opioid receptor mechanism in the production of psychological stress-induced analgesia.
    Takahashi M; Senda T; Tokuyama S; Kaneto H
    Jpn J Pharmacol; 1990 Aug; 53(4):487-94. PubMed ID: 2170723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
    Wettstein JG; Grouhel A
    Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE; Ho BY; Naeseth JS; Portoghese PS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.
    Endoh T; Matsuura H; Tanaka C; Nagase H
    Arch Int Pharmacodyn Ther; 1992; 316():30-42. PubMed ID: 1326932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN; Veeranna ; Reddy PL; Bhargava HN
    Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
    Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
    Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opioid analgesia is dependent on serotonergic mechanisms.
    Vonvoigtlander PF; Lewis RA; Neff GL
    J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentazocine-induced biphasic analgesia in mice.
    Suzuki T; Narita M; Misawa M; Nagase H
    Life Sci; 1991; 48(19):1827-35. PubMed ID: 1645834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.